ANGLE (LON:AGL) Given Buy Rating at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of ANGLE (LON:AGL) in a research report released on Wednesday morning, Marketbeat Ratings reports. The brokerage currently has a GBX 70 ($0.86) target price on the stock.

ANGLE Stock Performance

AGL opened at GBX 15.62 ($0.19) on Wednesday. The stock has a market capitalization of £40.70 million, a price-to-earnings ratio of -173.54 and a beta of 0.20. The company has a fifty day moving average of GBX 14.47 and a 200 day moving average of GBX 14.04. ANGLE has a fifty-two week low of GBX 9.07 ($0.11) and a fifty-two week high of GBX 37.40 ($0.46). The company has a debt-to-equity ratio of 14.26, a quick ratio of 6.18 and a current ratio of 7.51.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.